Protocol No.: NP40126

Title
A Phase 1B Study Evaluating RO7082859 In Combination with Rituximab (R) or Obinutuzumab (G) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants with Relapsed or Refractory Non-Hodgkin Lymphoma
Principal Investigator
Veltri, Lauren
Phase
I
Age Group
Adult
Applicable Disease Site
Lymphoma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Sylvia McEwuen, RN, CCRC
Study Coordinator/Research Nurse
Phone: +1 304-293-1683

View on ClinicalTrials.gov